What does this research mean for the field?

Soluble latent TGF-β can be effectively targeted by adapter CAR (AdCAR) T cells in combination with solid tumor-associated antigens, broadening the spectrum of targetable moieties for this therapy. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

November 11, 2022OncoImmunologyOpen Access

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells

View Full Paper

Ask AI

Bookmark

Abstract

. In sum, our study broadens the spectrum of targetable moieties for AdCAR T cells by soluble latent TGF-β.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Werchau et al. (2022) studied this question.

synapsesocial.com/papers/6a2584dad6861ce524e93a3f https://doi.org/10.1080/2162402x.2022.2140534

View Full Paper

Ask AI

Bookmark

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells

Abstract

Discussion

Cite This Study

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells

Abstract

Discussion

Cite This Study

Keep reading

Keep reading